Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1982 5
1983 2
1984 6
1985 4
1986 5
1987 8
1988 9
1989 8
1990 7
1991 12
1992 11
1993 17
1994 22
1995 15
1996 12
1997 17
1998 11
1999 20
2000 20
2001 16
2002 9
2003 18
2004 15
2005 20
2006 16
2007 25
2008 21
2009 21
2010 25
2011 21
2012 14
2013 20
2014 20
2015 15
2016 14
2017 20
2018 6
2019 18
2020 17
2021 13
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

538 results
Results by year
Filters applied: . Clear all
Page 1
Management of locally recurrent nasopharyngeal carcinoma.
Lee AWM, Ng WT, Chan JYW, Corry J, Mäkitie A, Mendenhall WM, Rinaldo A, Rodrigo JP, Saba NF, Strojan P, Suárez C, Vermorken JB, Yom SS, Ferlito A. Lee AWM, et al. Among authors: vermorken jb. Cancer Treat Rev. 2019 Sep;79:101890. doi: 10.1016/j.ctrv.2019.101890. Epub 2019 Aug 21. Cancer Treat Rev. 2019. PMID: 31470314 Review.
Platinum-based chemotherapy plus cetuximab in head and neck cancer.
Vermorken JB, Mesia R, Rivera F, Remenar E, Kawecki A, Rottey S, Erfan J, Zabolotnyy D, Kienzer HR, Cupissol D, Peyrade F, Benasso M, Vynnychenko I, De Raucourt D, Bokemeyer C, Schueler A, Amellal N, Hitt R. Vermorken JB, et al. N Engl J Med. 2008 Sep 11;359(11):1116-27. doi: 10.1056/NEJMoa0802656. N Engl J Med. 2008. PMID: 18784101 Free article. Clinical Trial.
Current management of stage IV nasopharyngeal carcinoma without distant metastasis.
Ng WT, Corry J, Langendijk JA, Lee AWM, Mäkitie A, Mendenhall WM, Rinaldo A, Rodrigo JP, Saba NF, Smee R, Strojan P, Suárez C, Vermorken JB, Ferlito A. Ng WT, et al. Among authors: vermorken jb. Cancer Treat Rev. 2020 Apr;85:101995. doi: 10.1016/j.ctrv.2020.101995. Epub 2020 Feb 21. Cancer Treat Rev. 2020. PMID: 32113080 Review.
Metastatic Squamous Cell Carcinoma to the Cervical Lymph Nodes From an Unknown Primary Cancer: Management in the HPV Era.
Civantos FJ, Vermorken JB, Shah JP, Rinaldo A, Suárez C, Kowalski LP, Rodrigo JP, Olsen K, Strojan P, Mäkitie AA, Takes RP, de Bree R, Corry J, Paleri V, Shaha AR, Hartl DM, Mendenhall W, Piazza C, Hinni M, Robbins KT, Tong NW, Sanabria A, Coca-Pelaz A, Langendijk JA, Hernandez-Prera J, Ferlito A. Civantos FJ, et al. Among authors: vermorken jb. Front Oncol. 2020 Nov 10;10:593164. doi: 10.3389/fonc.2020.593164. eCollection 2020. Front Oncol. 2020. PMID: 33244460 Free PMC article. Review.
Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy.
Chen YP, Wang YQ, Lv JW, Li YQ, Chua MLK, Le QT, Lee N, Colevas AD, Seiwert T, Hayes DN, Riaz N, Vermorken JB, O'Sullivan B, He QM, Yang XJ, Tang LL, Mao YP, Sun Y, Liu N, Ma J. Chen YP, et al. Among authors: vermorken jb. Ann Oncol. 2019 Jan 1;30(1):68-75. doi: 10.1093/annonc/mdy470. Ann Oncol. 2019. PMID: 30407504 Free article.
Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data.
Szturz P, Wouters K, Kiyota N, Tahara M, Prabhash K, Noronha V, Castro A, Licitra L, Adelstein D, Vermorken JB. Szturz P, et al. Among authors: vermorken jb. Oncologist. 2017 Sep;22(9):1056-1066. doi: 10.1634/theoncologist.2017-0015. Epub 2017 May 22. Oncologist. 2017. PMID: 28533474 Free PMC article. Review.
Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.
Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M, Stewart JS, Jelic S, Betka J, Preiss JH, van den Weyngaert D, Awada A, Cupissol D, Kienzer HR, Rey A, Desaunois I, Bernier J, Lefebvre JL; EORTC 24971/TAX 323 Study Group. Vermorken JB, et al. N Engl J Med. 2007 Oct 25;357(17):1695-704. doi: 10.1056/NEJMoa071028. N Engl J Med. 2007. PMID: 17960012 Free article. Clinical Trial.
Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874).
Reed NS, Mangioni C, Malmström H, Scarfone G, Poveda A, Pecorelli S, Tateo S, Franchi M, Jobsen JJ, Coens C, Teodorovic I, Vergote I, Vermorken JB; European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group. Reed NS, et al. Among authors: vermorken jb. Eur J Cancer. 2008 Apr;44(6):808-18. doi: 10.1016/j.ejca.2008.01.019. Epub 2008 Apr 2. Eur J Cancer. 2008. PMID: 18378136 Clinical Trial.
538 results